Wall Street Zen upgraded shares of Bioceres Crop Solutions (NASDAQ:BIOX – Free Report) from a sell rating to a hold rating in a report published on Saturday.
A number of other brokerages also recently issued reports on BIOX. Canaccord Genuity Group reduced their price target on Bioceres Crop Solutions from $2.50 to $2.25 and set a “hold” rating on the stock in a report on Friday, November 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, November 17th. Lake Street Capital dropped their price target on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Brookline Capital Management cut shares of Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 21st. Finally, Oppenheimer downgraded shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $4.08.
Read Our Latest Stock Analysis on BIOX
Bioceres Crop Solutions Price Performance
Institutional Investors Weigh In On Bioceres Crop Solutions
Several hedge funds have recently bought and sold shares of BIOX. Jones Financial Companies Lllp increased its stake in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares during the last quarter. PDT Partners LLC bought a new position in Bioceres Crop Solutions during the 1st quarter valued at approximately $81,000. Avanza Fonder AB increased its position in Bioceres Crop Solutions by 62.9% during the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock valued at $117,000 after buying an additional 10,099 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in Bioceres Crop Solutions during the third quarter valued at $40,000. Institutional investors own 17.68% of the company’s stock.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- How Technical Indicators Can Help You Find Oversold StocksĀ
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- What is the MACD Indicator and How to Use it in Your Trading
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Most Volatile Stocks, What Investors Need to Know
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
